{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:53:36Z","timestamp":1791237216584,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council\u00a0of\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.metabol.2019.154044","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T12:25:51Z","timestamp":1575548751000},"page":"154044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents"],"prefix":"10.1016","volume":"103","author":[{"given":"Anagha Ashok","family":"Gurjar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sapana","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabanita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashis","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamsundar Pal","family":"China","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajdeep","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naibedya","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabyasachi","family":"Sanyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2019.154044_bb0005","doi-asserted-by":"crossref","first-page":"11e","DOI":"10.1016\/j.amjcard.2008.02.074","article-title":"Hypercatabolic syndrome: molecular basis and effects of nutritional supplements with amino acids","volume":"101","author":"Pasini","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2019.154044_bb0010","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2337\/dc09-0264","article-title":"Excessive loss of skeletal muscle mass in older adults with type 2 diabetes","volume":"32","author":"Park","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2019.154044_bb0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S2213-8587(14)70034-8","article-title":"Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases","volume":"2","author":"Kalyani","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.metabol.2019.154044_bb0020","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11926-010-0104-3","article-title":"Drug-related myopathies of which the clinician should be aware","volume":"12","author":"Valiyil","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.metabol.2019.154044_bb0025","first-page":"1","article-title":"Oral drugs related with muscle wasting and sarcopenia","volume":"99","author":"Campins","year":"2017","journal-title":"A Review Pharmacology"},{"key":"10.1016\/j.metabol.2019.154044_bb0030","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1096\/fj.03-0610com","article-title":"Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression","volume":"18","author":"Lecker","year":"2004","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2019.154044_bb0035","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00204.2014","article-title":"Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx\/atrogin-1","volume":"307","author":"Bodine","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2019.154044_bb0040","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0092-8674(04)00400-3","article-title":"Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy","volume":"117","author":"Sandri","year":"2004","journal-title":"Cell."},{"key":"10.1016\/j.metabol.2019.154044_bb0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1152\/jappl.2001.91.2.534","article-title":"Myogenic satellite cells: physiology to molecular biology","volume":"91","author":"Hawke","year":"2001","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.metabol.2019.154044_bb0050","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1172\/JCI40373","article-title":"Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells","volume":"120","author":"Tedesco","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2019.154044_bb0055","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tcb.2016.02.004","article-title":"Satellite cell heterogeneity in skeletal muscle homeostasis","volume":"26","author":"Tierney","year":"2016","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.metabol.2019.154044_bb0060","doi-asserted-by":"crossref","first-page":"957014","DOI":"10.1155\/2014\/957014","article-title":"Cellular players in skeletal muscle regeneration","volume":"2014","author":"Ceafalan","year":"2014","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.metabol.2019.154044_bb0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcdb.2017.11.010","article-title":"The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration","volume":"72","author":"Hernandez-Hernandez","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.metabol.2019.154044_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.semcdb.2017.11.011","article-title":"Function of the myogenic regulatory factors Myf5, MyoD, myogenin and MRF4 in skeletal muscle, satellite cells and regenerative myogenesis","volume":"72","author":"Zammit","year":"2017","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.metabol.2019.154044_bb0075","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2019.154044_bb0080","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nbt.3557","article-title":"No longer going to waste","volume":"34","author":"Garber","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.metabol.2019.154044_bb0085","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.drudis.2015.05.001","article-title":"Drug repositioning and repurposing: terminology and definitions in literature","volume":"20","author":"Langedijk","year":"2015","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.metabol.2019.154044_bb0090","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1177\/1060028015586806","article-title":"Liraglutide: an injectable option for the management of obesity","volume":"49","author":"Clements","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.metabol.2019.154044_bb0095","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-143090","article-title":"The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer's disease","volume":"46","author":"Hansen","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.metabol.2019.154044_bb0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease","volume":"245","author":"Batista","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.metabol.2019.154044_bb0105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/db08-1193","article-title":"GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice","volume":"58","author":"Noyan-Ashraf","year":"2009","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.154044_bb0110","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.amjcard.2018.02.030","article-title":"Myocardial infarction subtypes in patients with type 2 diabetes mellitus and the effect of liraglutide therapy (from the LEADER trial)","volume":"121","author":"Marso","year":"2018","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.metabol.2019.154044_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcp.2019.03.024","article-title":"The osteogenic effect of liraglutide involves enhanced mitochondrial biogenesis in osteoblasts","volume":"164","author":"Pal","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.metabol.2019.154044_bb0120","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.mce.2016.09.013","article-title":"Small molecule adiponectin receptor agonist GTDF protects against skeletal muscle atrophy","volume":"439","author":"Singh","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2019.154044_bb0125","first-page":"227","article-title":"Muscle atrophy and regeneration associated with behavioural loss and recovery of function after sciatic nerve crush","volume":"e13335","author":"Gronholdt-Klein","year":"2019","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.metabol.2019.154044_bb0130","series-title":"Exp Anim","article-title":"Muscle weakness and impaired motor coordination in Hcn1-deficient rats","author":"Nishitani","year":"2019"},{"key":"10.1016\/j.metabol.2019.154044_bb0135","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.2337\/db13-1619","article-title":"Orally active osteoanabolic agent GTDF binds to adiponectin receptors, with a preference for AdipoR1, induces adiponectin-associated signaling, and improves metabolic health in a rodent model of diabetes","volume":"63","author":"Singh","year":"2014","journal-title":"Diabetes."},{"key":"10.1016\/j.metabol.2019.154044_bb0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas","volume":"113","author":"Doyle","year":"2007","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.metabol.2019.154044_bb0145","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.7150\/thno.15993","article-title":"Activation of GLP-1 receptor enhances neuronal base excision repair via PI3K-AKT-Induced expression of Apurinic\/Apyrimidinic Endonuclease 1","volume":"6","author":"Yang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.metabol.2019.154044_bb0150","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1463-1326.2011.01431.x","article-title":"GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice","volume":"13","author":"Jolivalt","year":"2011","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.metabol.2019.154044_bb0155","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1006\/bbrc.2000.2514","article-title":"Wortmannin, a PI3-kinase inhibitor: promoting effect on insulin secretion from pancreatic beta cells through a cAMP-dependent pathway","volume":"270","author":"Nunoi","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2019.154044_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0960-9822(06)00122-9","article-title":"Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha","volume":"7","author":"Alessi","year":"1997","journal-title":"Curr Biol"},{"key":"10.1016\/j.metabol.2019.154044_bb0165","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ceb.2009.02.002","article-title":"PIKKing on PKB: regulation of PKB activity by phosphorylation","volume":"21","author":"Bozulic","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.metabol.2019.154044_bb0170","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/JOE-13-0172","article-title":"PI3 kinase directly phosphorylates Akt1\/2 at Ser473\/474 in the insulin signal transduction pathway","volume":"220","author":"Tsuchiya","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/j.metabol.2019.154044_bb0175","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s13539-012-0074-6","article-title":"Molecular and cellular mechanisms of skeletal muscle atrophy: an update","volume":"3","author":"Fanzani","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.metabol.2019.154044_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00001756-199101000-00006","article-title":"Influence of innervation of myogenic factors and acetylcholine receptor alpha-subunit mRNAs","volume":"2","author":"Duclert","year":"1991","journal-title":"Neuroreport."},{"key":"10.1016\/j.metabol.2019.154044_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142699","article-title":"Investigation of the expression of myogenic transcription factors, microRNAs and muscle-specific E3 ubiquitin ligases in the medial gastrocnemius and soleus muscles following peripheral nerve injury","volume":"10","author":"Wiberg","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2019.154044_bb0190","first-page":"561","article-title":"The effect of MyoD family proteins on muscular atrophy induced by brachial plexus injury in rats","volume":"82","author":"Wu","year":"2002","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.metabol.2019.154044_bb0195","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0304-4165(99)00086-0","article-title":"The adaptive response of MyoD family proteins in overloaded, regenerating and denervated rat muscles","volume":"1428","author":"Sakuma","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.metabol.2019.154044_bb0205","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0955-0674(96)80091-3","article-title":"Skeletal muscle determination and differentiation: story of a core regulatory network and its context","volume":"8","author":"Yun","year":"1996","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.metabol.2019.154044_bb0210","doi-asserted-by":"crossref","first-page":"34359","DOI":"10.1074\/jbc.M003815200","article-title":"CREB-binding protein\/p300 activates MyoD by acetylation","volume":"275","author":"Polesskaya","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2019.154044_bb0215","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mce.2009.09.028","article-title":"Involvement of cAMP\/Epac\/PI3K-dependent pathway in the antiproteolytic effect of epinephrine on rat skeletal muscle","volume":"315","author":"Baviera","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2019.154044_bb0220","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.cellsig.2005.03.011","article-title":"Adrenaline potentiates insulin-stimulated PKB activation via cAMP and Epac: implications for cross talk between insulin and adrenaline","volume":"17","author":"Brennesvik","year":"2005","journal-title":"Cell Signal"},{"key":"10.1016\/j.metabol.2019.154044_bb0225","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1152\/japplphysiol.00499.2017","article-title":"Involvement of cAMP\/EPAC\/Akt signaling in the antiproteolytic effects of pentoxifylline on skeletal muscles of diabetic rats","volume":"124","author":"Arcaro","year":"2018","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.metabol.2019.154044_bb0230","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2044-5040-1-29","article-title":"The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis","volume":"1","author":"Knight","year":"2011","journal-title":"Skeletal Muscle"},{"key":"10.1016\/j.metabol.2019.154044_bb0235","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1091\/mbc.e03-05-0351","article-title":"Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturation","volume":"15","author":"Wilson","year":"2004","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.metabol.2019.154044_bb0240","doi-asserted-by":"crossref","first-page":"C1292","DOI":"10.1152\/ajpcell.00259.2012","article-title":"Defining Akt actions in muscle differentiation","volume":"303","author":"Gardner","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.metabol.2019.154044_bb0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tcb.2005.11.002","article-title":"Regulation of skeletal muscle gene expression by p38 MAP kinases","volume":"16","author":"Lluis","year":"2006","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.metabol.2019.154044_bb0250","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1128\/MCB.20.11.3951-3964.2000","article-title":"p38 and Extracellular signal-regulated kinases regulate the myogenic program at multiple steps","volume":"20","author":"Wu","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.metabol.2019.154044_bb0255","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1242\/dev.107078","article-title":"Nuclear to cytoplasmic shuttling of ERK promotes differentiation of muscle stem\/progenitor cells","volume":"141","author":"Michailovici","year":"2014","journal-title":"Development."},{"key":"10.1016\/j.metabol.2019.154044_bb0260","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1096\/fj.11-189977","article-title":"Inhibition of FoxO transcriptional activity prevents muscle fiber atrophy during cachexia and induces hypertrophy","volume":"26","author":"Reed","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2019.154044_bb0265","doi-asserted-by":"crossref","first-page":"11960","DOI":"10.1073\/pnas.220413597","article-title":"Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase a","volume":"97","author":"Fang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2019.154044_bb0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2044-5040-1-4","article-title":"Regulation of skeletal muscle growth by the IGF1-Akt\/PKB pathway: insights from genetic models","volume":"1","author":"Schiaffino","year":"2011","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.metabol.2019.154044_bb0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024714","article-title":"CREB is activated by muscle injury and promotes muscle regeneration","volume":"6","author":"Stewart","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.metabol.2019.154044_bb0280","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/embj.201386145","article-title":"Creb coactivators direct anabolic responses and enhance performance of skeletal muscle","volume":"33","author":"Bruno","year":"2014","journal-title":"EMBO J"},{"key":"10.1016\/j.metabol.2019.154044_bb0285","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1242\/jcs.02908","article-title":"Pax7 and myogenic progression in skeletal muscle satellite cells","volume":"119","author":"Zammit","year":"2006","journal-title":"J Cell Sci"},{"key":"10.1016\/j.metabol.2019.154044_bb0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00043.2011","article-title":"Satellite cells and the muscle stem cell niche","volume":"93","author":"Yin","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/j.metabol.2019.154044_bb0295","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1083\/jcb.200312007","article-title":"Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?","volume":"166","author":"Zammit","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.metabol.2019.154044_bb0300","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1083\/jcb.200608122","article-title":"Reciprocal inhibition between Pax7 and muscle regulatory factors modulates myogenic cell fate determination","volume":"177","author":"Olguin","year":"2007","journal-title":"J Cell Biol"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519302598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049519302598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:23:46Z","timestamp":1758428626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049519302598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":59,"alternative-id":["S0026049519302598"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2019.154044","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2019.154044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154044"}}